MedTrace Logo

Metoclopramide for Post-Traumatic Headache. A Pilot Study

NCT03056352 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2018-07-31

Study results available
· View outcomes & findings →

Summary

Post-traumatic headache is common. We are determining short and longer-term outcomes among patients treated for post-traumatic headache with IV metoclopramide.

Conditions

  • Post-Traumatic Headache

Interventions

DRUG

Metoclopramide

Intravenous medication drip

DRUG

Diphenhydramine

Intravenous medication drip

Sponsors & Collaborators

  • Montefiore Medical Center

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2017-07-20
Completion
2017-08-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03056352 on ClinicalTrials.gov